AbbVie (ABBV) stock consensus forecasts for the month and 2024 - 2028.
Last update: 10/15/2024, 01:05 AM
Brief information about AbbVie Inc.
Last trading day: 10/14/2024
Analyst forecast price: $169.54
52-week high/low: $164.87 / $127.03
Shares of AbbVie Inc. are traded on the stock exchange under the ticker ABBV and belong to the "Healthcare" sector. The head office is currently located at: 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, US. The market capitalization of AbbVie is $290 908 013 000. At the same time, the number of shares in circulation is 1 765 540 000. The company's earnings before interest, taxes and depreciation for last year (called EBITDA) was 27 993 000 000$. The company has a good profit. The PE ratio according to the latest reporting is at around 45.02. P/E shows the investor how many years his investment in this business pays off. That is, investments in AbbVie shares will pay off in about 46 years. A very long payback period of investments, shares should be considered not as an investment idea, but as a speculative one.
In addition to fundamental factors, stocks are influenced by many other factors. For example, it is worth monitoring all global forecasts for AbbVie shares. Our service will help you with this, in which we collect all forecasts and build one consensus forecast from them.
AbbVie stock forecast
For investing in AbbVie stock, the investor is interested in the long-term outlook. We have collected for you all the forecasts of world analysts for the shares of this company and combined them into one consensus forecast for 2024, 2025, 2026, 2027, 2028?
After studying the forecasts, we can answer the questions:
How much will one share of AbbVie cost in 2024, 2025, 2026, 2027, 2028?
What is the consensus analyst forecast for AbbVie stock?
Should you buy AbbVie stock short term or long term?
Should I sell AbbVie shares in 2024 or wait?
Should I buy AbbVie stock in 2024 or wait?
Where is the estimated entry/exit point in AbbVie stock?
But remember, these forecasts are not investment ideas. You are fully responsible for the decisions you make.
How is a forecast made?
We collect public data about AbbVie and analyst forecasts for AbbVie stock. Next, the algorithms calculate a weighted average forecast, removing extreme values. As a result, at the output we get an updated forecast, as close as possible to reality.
AbbVie daily forecast for a month
After collecting analysts' forecasts, we made one average daily forecast for AbbVie shares for the next month. Short-term forecasts are characterized by rather low accuracy due to many factors influencing them. But let's see what we got.
Below on the page is a graph of the consensus forecast for AbbVie stock for the next month. (30 days). The gray color on the chart shows the historical price of the stock. The turquoise color shows the price forecast with a possible range of fluctuations.
The maximum target price that AbbVie shares will reach in the next 30 days is $240.79. This is the upper limit of the target price range. This represents upside potential of 23.07% from current levels.
In turn, the minimum value that the price can reach in 30 days is $183.67. From the current price, the drop will be 6.52%.
Thus, on the monthly timeframe, a channel is formed with a resistance level of $240.79 and a support level of $183.67. The width of this channel is $57.12. Accordingly, according to the theory of technical analysis, a downward breakdown of the channel will open the way to $127. If the resistance level is broken, then the road to $298 per share of AbbVie will open.
What is the probability of exiting the channel up? Near the level of the upper border of the channel, the stock price will be traded for only 1 day. The chances of breaking through the resistance level of AbbVie shares in the next 30 days or in the next period are very small. It is worth considering that if stocks break through the $240.79 resistance level and try to gain a foothold above it, then in the future they will most likely test this level from above and if the $240.79 mark holds, then this will be a new channel with new goals.
How about testing the strength of the support level? The price will stay near the support level for 3 days. There is a good chance that the stock will break through the $183.67 support level.
In addition, the real future price of one AbbVie share can be both higher and lower than the target forecast price, but approximately in the range between the pessimistic and optimistic target price.
Date | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Oct 17 | 195.16 | 187.43 | 201.72 | 7.62 |
Oct 18 | 190.83 | 187.05 | 198.39 | 6.06 |
Oct 19 | 189.00 | 183.67 | 193.08 | 5.12 |
Oct 20 | 193.42 | 190.05 | 197.36 | 3.85 |
Oct 21 | 202.35 | 199.32 | 206.24 | 3.47 |
Oct 22 | 213.16 | 210.09 | 218.53 | 4.02 |
Oct 23 | 213.54 | 204.32 | 221.87 | 8.59 |
Oct 24 | 212.90 | 206.90 | 222.36 | 7.47 |
Oct 25 | 208.56 | 201.93 | 217.32 | 7.62 |
Oct 26 | 204.81 | 195.84 | 212.18 | 8.35 |
Oct 27 | 210.70 | 204.64 | 219.43 | 7.23 |
Oct 28 | 220.69 | 214.73 | 228.77 | 6.54 |
Oct 29 | 219.90 | 214.88 | 228.47 | 6.32 |
Oct 30 | 219.63 | 216.87 | 223.85 | 3.22 |
Oct 31 | 218.58 | 212.42 | 222.25 | 4.63 |
Nov 01 | 216.87 | 211.54 | 223.38 | 5.60 |
Nov 02 | 217.26 | 210.75 | 220.91 | 4.82 |
Nov 03 | 219.87 | 211.17 | 230.43 | 9.12 |
Nov 04 | 215.25 | 207.51 | 221.07 | 6.54 |
Nov 05 | 211.90 | 207.70 | 214.69 | 3.37 |
Nov 06 | 209.10 | 206.47 | 212.24 | 2.80 |
Nov 07 | 212.49 | 209.30 | 217.84 | 4.08 |
Nov 08 | 224.47 | 217.20 | 232.42 | 7.01 |
Nov 09 | 224.88 | 220.56 | 232.30 | 5.32 |
Nov 10 | 230.95 | 221.80 | 240.79 | 8.56 |
Nov 11 | 224.43 | 220.93 | 232.24 | 5.12 |
Nov 12 | 221.74 | 211.76 | 230.26 | 8.73 |
Nov 13 | 211.90 | 207.19 | 216.09 | 4.30 |
Nov 14 | 211.13 | 207.59 | 214.93 | 3.54 |
Nov 15 | 200.49 | 191.23 | 206.51 | 7.99 |
AbbVie Stock Forecast 17 Oct.
AbbVie Stock Forecast 18 Oct.
AbbVie Stock Forecast 19 Oct.
AbbVie Stock Forecast 20 Oct.
AbbVie Stock Forecast 21 Oct.
AbbVie Stock Forecast 22 Oct.
AbbVie Stock Forecast 23 Oct.
AbbVie Stock Forecast 24 Oct.
AbbVie Stock Forecast 26 Oct.
AbbVie Stock Forecast 27 Oct.
AbbVie Stock Forecast 28 Oct.
AbbVie Stock Forecast 29 Oct.
AbbVie Stock Forecast 30 Oct.
AbbVie Stock Forecast 31 Oct.
AbbVie Stock Forecast 01 Nov.
AbbVie Stock Forecast 02 Nov.
AbbVie Stock Forecast 03 Nov.
AbbVie Stock Forecast 04 Nov.
AbbVie Stock Forecast 05 Nov.
AbbVie monthly stock forecast for 2024, 2025, 2026, 2027, 2028.
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Nov. | 217.85 | 195.76 | 231.72 | 15.52 |
Dec. | 241.92 | 234.06 | 258.27 | 9.38 |
Now let's look at the monthly consensus forecast for this year and beyond. The forecast is also based on the forecasts of world analysts, which are in the public domain. Forecasts for the year are medium-term and less dependent on external factors, and therefore more accurate than daily forecasts.
This year, the maximum possible price per AbbVie share is projected at $258.27. Peak forecasts from some agencies, which vary greatly in price, we have omitted.
The minimum levels for AbbVie shares for this year are $195.76.
Similarly, we calculated the consensus forecasts for the coming years, which are summarized in tables for convenience.
AbbVie (ABBV) Monthly Stock Prediction for 2025
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 242.86 | 221.39 | 252.33 | 12.26 |
Feb | 228.34 | 214.69 | 249.42 | 13.92 |
Mar | 214.09 | 196.28 | 219.66 | 10.64 |
Apr | 220.77 | 197.81 | 238.28 | 16.98 |
May | 229.38 | 219.54 | 245.48 | 10.57 |
Jun | 225.21 | 202.66 | 247.16 | 18.00 |
Jul | 234.28 | 221.79 | 242.51 | 8.54 |
Aug | 262.91 | 251.29 | 278.98 | 9.92 |
Sep | 245.14 | 233.98 | 256.93 | 8.93 |
Oct | 237.81 | 223.28 | 254.19 | 12.16 |
Nov | 248.32 | 228.95 | 267.04 | 14.26 |
Dec | 261.88 | 244.18 | 284.35 | 14.13 |
AbbVie (ABBV) Monthly Stock Prediction for 2026
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 274.47 | 253.07 | 301.59 | 16.09 |
Feb | 308.37 | 279.11 | 338.44 | 17.53 |
Mar | 305.97 | 278.52 | 327.45 | 14.94 |
Apr | 307.96 | 299.15 | 334.78 | 10.64 |
May | 301.15 | 281.18 | 316.03 | 11.03 |
Jun | 273.35 | 264.47 | 291.12 | 9.15 |
Jul | 275.13 | 252.96 | 302.67 | 16.43 |
Aug | 289.44 | 261.59 | 318.41 | 17.84 |
Sep | 276.27 | 268.73 | 288.84 | 6.96 |
Oct | 303.56 | 284.23 | 311.85 | 8.86 |
Nov | 338.69 | 329.88 | 372.15 | 11.36 |
Dec | 317.11 | 303.09 | 341.43 | 11.23 |
AbbVie (ABBV) Monthly Stock Prediction for 2027
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 320.41 | 288.75 | 331.24 | 12.83 |
Feb | 318.33 | 295.15 | 334.88 | 11.86 |
Mar | 331.98 | 316.01 | 344.07 | 8.15 |
Apr | 296.16 | 273.83 | 307.33 | 10.90 |
May | 257.66 | 241.58 | 273.74 | 11.75 |
Jun | 273.07 | 254.61 | 280.88 | 9.35 |
Jul | 266.32 | 257.32 | 283.29 | 9.17 |
Aug | 250.05 | 241.60 | 266.96 | 9.50 |
Sep | 235.42 | 228.08 | 247.05 | 7.68 |
Oct | 237.26 | 215.05 | 250.21 | 14.05 |
Nov | 245.90 | 227.04 | 254.21 | 10.69 |
Dec | 250.05 | 238.35 | 263.70 | 9.61 |
AbbVie (ABBV) Monthly Stock Prediction for 2028
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 243.55 | 218.54 | 268.88 | 18.72 |
Feb | 221.70 | 205.56 | 233.23 | 11.86 |
Mar | 213.92 | 200.57 | 234.22 | 14.37 |
Apr | 213.92 | 205.02 | 228.66 | 10.34 |
May | 216.43 | 202.36 | 228.80 | 11.56 |
Jun | 220.36 | 199.74 | 230.39 | 13.30 |
Jul | 215.21 | 197.30 | 234.79 | 15.97 |
Aug | 218.84 | 206.04 | 230.51 | 10.61 |
Sep | 234.21 | 225.68 | 250.65 | 9.96 |
Oct | 220.81 | 215.07 | 236.89 | 9.21 |
Nov | 220.24 | 201.34 | 235.70 | 14.58 |
Dec | 225.96 | 218.03 | 241.53 | 9.73 |
Stocks from the same sector (Healthcare)
Other securities
All submitted consensus forecasts are exposed to get acquainted with the algorithm for collecting forecasts and bringing them to a single whole. The portal updownforecast.info is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.